Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

WRBY

Warby Parker Inc

Feb 06 • 04:00PM ET

25.52

+1.71 7.18 %

Healthcare • Medical Instruments & Supplies • USA • NYSE

Peers: AMZN TGT WMT COST BBY DG DLTR M KSS JWN

| Held by: VTI IWM VB VBK VXF IWO JTEK SCHA VTWO SAMT

Index	RUT	P/E	6715.79	EPS (ttm)	0.00	Insider Own	18.56%	Shs Outstand	105.60M	Perf Week	0.04%
Market Cap	3.12B	Forward P/E	51.53	EPS next Y	0.50	Insider Trans	-5.03%	Shs Float	99.49M	Perf Month	-5.73%
Enterprise Value	3.07B	PEG	1.83	EPS next Q	0.05	Inst Own	81.19%	Short Float	10.60%	Perf Quarter	33.96%
Income	0.72M	P/S	3.67	EPS this Y	20.05%	Inst Trans	6.22%	Short Ratio	2.49	Perf Half Y	8.69%
Sales	850.58M	P/B	8.43	EPS next Y	34.40%	ROA	0.11%	Short Interest	10.55M	Perf YTD	17.12%
Book/sh	3.03	P/C	11.12	EPS next 5Y	28.20%	ROE	0.20%	52W High	31.00 -17.68%	Perf Year	-5.17%
Cash/sh	2.29	P/FCF	82.50	EPS past 3/5Y	50.37% 19.99%	ROIC	0.13%	52W Low	13.63 87.23%	Perf 3Y	53.09%
Dividend Est.	-	EV/EBITDA	68.85	Sales past 3/5Y	12.56% 15.80%	Gross Margin	52.37%	Volatility	6.78% 6.36%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.61	EPS Y/Y TTM	101.94%	Oper. Margin	-0.87%	ATR (14)	1.69	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.23	Sales Y/Y TTM	14.55%	Profit Margin	0.08%	RSI (14)	48.66	Recom	1.79
Dividend Gr. 3/5Y	- -	Current Ratio	2.58	EPS Q/Q	238.87%	SMA20	-4.75%	Beta	2.06	Target Price	27.83
Payout	-	Debt/Eq	0.63	Sales Q/Q	15.19%	SMA50	2.02%	Rel Volume	0.53	Prev Close	23.81
Employees	3780	LT Debt/Eq	0.55	Earnings	Nov 06 BMO	SMA200	11.27%	Avg Volume	4.23M	Price	25.52
IPO	Sep 29, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	31.57% -1.07%	Trades		Volume	2,225,630	Change	7.18%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$30
Nov-07-25	Reiterated	Telsey Advisory Group	Outperform	$28 → $24
Aug-01-25	Reiterated	Telsey Advisory Group	Outperform	$22 → $28
Jul-10-25	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Apr-30-25	Upgrade	Citigroup	Sell → Neutral	$17
Apr-17-25	Upgrade	Loop Capital	Hold → Buy	$27
Feb-28-25	Reiterated	Telsey Advisory Group	Outperform	$28 → $30
Feb-25-25	Initiated	ROTH MKM	Neutral	$26
Feb-05-25	Downgrade	Citigroup	Neutral → Sell	$19 → $23
Jan-17-25	Downgrade	Evercore ISI	Outperform → In-line	$23
Nov-19-24	Reiterated	Telsey Advisory Group	Outperform	$22 → $26
Nov-08-24	Reiterated	Telsey Advisory Group	Outperform	$19 → $22
Nov-07-24	Upgrade	William Blair	Mkt Perform → Outperform
Oct-21-24	Upgrade	Goldman	Neutral → Buy	$15 → $18
Aug-23-24	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$20
Aug-23-24	Resumed	Piper Sandler	Overweight	$18
Oct-12-23	Upgrade	BTIG Research	Neutral → Buy	$17
Oct-03-23	Upgrade	Evercore ISI	In-line → Outperform	$20
Sep-25-23	Initiated	UBS	Neutral	$13
Jun-27-23	Initiated	William Blair	Mkt Perform

Show Previous Ratings

Feb-03-26 08:55PM	Warby Parker Inc. (WRBY): A Bull Case Theory (Insider Monkey)
05:35PM	Clorox (CLX) Misses Q2 Earnings Estimates (Zacks)
Jan-30-26 05:52AM	Big Tech thinks smart glasses will be the first major piece of AI hardware (Yahoo Finance) -5.03%
Jan-28-26 03:01PM	Why Warby Parker (WRBY) Shares Are Plunging Today (StockStory) -7.04%
09:02AM	Snap seeks investments as new smart glasses unit takes on Meta (Reuters)
09:02AM	Loading…
09:02AM	Snap doubles down on smart glasses with new independent unit (Reuters)
Jan-25-26 10:32PM	Q3 Earnings Highlights: Warby Parker (NYSE:WRBY) Vs The Rest Of The Beauty and Cosmetics Retailer Stocks (StockStory)
Jan-23-26 07:36AM	Riverwater Partners Small Cap Strategy's Investment Thesis for Warby Parker (WRBY) (Insider Monkey)
Jan-14-26 07:09AM	Warby Parker (WRBY) Soars 9.4% on Strong AI Glasses Demand (Insider Monkey)
Jan-13-26 11:05PM	3 Big Reasons to Love Warby Parker (WRBY) (StockStory) +9.44%
Jan-12-26 01:30PM	Why Warby Parker (WRBY) Shares Are Getting Obliterated Today (StockStory) -6.08%
Jan-06-26 07:31PM	Warby Parker (WRBY) Soars 11% on PT Hike, AI Glasses Optimism (Insider Monkey) +11.57%
12:29PM	Meta Delays International Rollout for Ray-Ban Display Glasses (Barrons.com)
12:29PM	Meta Delays International Rollout for Ray-Ban Display Glasses Amid Strong Demand (Barrons.com)
Jan-05-26 12:15PM	Why Warby Parker (WRBY) Stock Is Trading Up Today (StockStory)
01:46PM	Loading…
Jan-02-26 01:46PM	Warby Parker (WRBY) Stock Is Up, What You Need To Know (StockStory)
Dec-23-25 11:48AM	Marissa Mayers new startup Dazzle raises $8M led by Forerunners Kirsten Green (TechCrunch)
Dec-17-25 01:01PM	Warby Parker (WRBY) Stock Trades Up, Here Is Why (StockStory)
Dec-15-25 10:45AM	Google Is Planning to Launch AI Glasses in 2026. This 1 Stock to Buy Could Be the Biggest Winner. (Barchart)
Dec-14-25 02:41PM	Warby Parker (WRBY) Climbs 46% Ahead of 2026 AI Development (Insider Monkey)
Dec-13-25 07:00AM	4 Signs Your Startup Is Fundable, According To Top Investors (Black Enterprise)
Dec-11-25 10:19AM	Warby Parker (WRBY) Nears 4-Month High on Looming AI Glass Launch (Insider Monkey)
Dec-10-25 02:09PM	Is Google Stock a Buy Ahead of Its First AI Glasses Launch? (Barchart) +27.35%
10:35AM	EchoStar, Warby Parker, Cracker Barrel: Top Analyst Calls (Yahoo Finance Video)
Dec-09-25 04:54PM	Biggest Market Movers Today, Dec. 9: WRBY, DYN, & More (Motley Fool) +9.22%
02:22PM	Warby Parker (WRBY) Soars 13% Ahead of AI Glasses Launch (Insider Monkey)
02:16PM	Why Warby Parker (WRBY) Stock Is Up Today (StockStory)
11:14AM	Ray-Ban Meta glasses take off but face privacy and competition test (Reuters)
11:00AM	4 signs your startup is fundable, according to top investors (Stacker)
Dec-08-25 07:26PM	Why Warby Parker Stock Was a Winner Today (Motley Fool) +13.27%
07:00AM	Loading…
Nov-26-25 07:00AM	Warby Parker Announces Participation in the Morgan Stanley Global Consumer & Retail Conference (Business Wire)
Nov-18-25 01:21PM	Tales of Unexpected Losses: AXON, TREX, WRBY (Motley Fool)
Nov-13-25 12:32AM	Warby Parker's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Nov-12-25 10:38AM	Simon Unveils Rewards-stacked Loyalty Program (WWD)
Nov-07-25 09:41AM	WRBY Q3 Deep Dive: Revenue Miss and Guidance Reduction Amid Changing Consumer Trends (StockStory)
09:30AM	Warby Parker (WRBY) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
Nov-06-25 02:09PM	Warby Parker Inc (WRBY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) -11.13%
01:56PM	Warby Parker (WRBY) Stock Trades Down, Here Is Why (StockStory)
12:16PM	Why Warby Parker Stock Is Plummeting Today (Motley Fool)
07:55AM	Warby Parker Inc. (WRBY) Q3 Earnings Top Estimates (Zacks)
07:15AM	Warby Parker (NYSE:WRBY) Misses Q3 Sales Expectations, Stock Drops (StockStory)
06:45AM	Warby Parker Announces Third Quarter 2025 Results (Business Wire)
Nov-05-25 07:31AM	Warby Parker Inc (WRBY) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-04-25 10:09PM	Warby Parker (WRBY) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-31-25 03:21PM	Warby Parker (WRBY) Stock Is Up, What You Need To Know (StockStory)
Oct-16-25 07:00AM	Warby Parker to Announce Third Quarter 2025 Financial Results November 6, 2025 (Business Wire)
Oct-08-25 12:02AM	2 Reasons to Watch WRBY and 1 to Stay Cautious (StockStory)
Oct-07-25 11:36PM	Winners And Losers Of Q2: Warby Parker (NYSE:WRBY) Vs The Rest Of The Beauty and Cosmetics Retailer Stocks (StockStory)
Oct-05-25 03:53PM	What's a Supernova Stock? 3 Ideas for Your Watch List. (Motley Fool)
Sep-23-25 05:35AM	Warby Parkers Neil Blumenthal on whats next for the brand (Retail Dive)
Sep-22-25 10:22AM	The Motley Fool Interviews Dave Gilboa, Co-Founder and Co-CEO of Warby Parker (Motley Fool)
Sep-16-25 10:43AM	Meta Stock Rises. This Is Its New AI Product. (Barrons.com)
Sep-11-25 09:00AM	Warby Parker (WRBY) Rose Following the Partnership Announcement with Google (Insider Monkey)
Sep-05-25 04:23PM	Time to Buy? (Motley Fool)
Aug-28-25 04:05PM	Warby Parker Announces Participation in the Goldman Sachs 32nd Annual Global Retailing Conference (Business Wire)
Aug-27-25 10:27PM	Eyewear giant Warby Parker has a huge new sports partnership (TheStreet)
09:00AM	Warby Parker Teams Up with Arch Manning for Three-Year Partnership (Business Wire)
Aug-14-25 04:45PM	Warby Parker, Tilly's, Advance Auto Parts, RH, and Victoria's Secret Shares Plummet, What You Need To Know (StockStory)
01:33AM	The 5 Most Interesting Analyst Questions From Warby Parker's Q2 Earnings Call (StockStory)
Aug-13-25 12:05PM	Drivepoint Adds $9M From Top Tech And Consumer Investors To Accelerate AI Finance Platform For Retail Brands (PR Newswire) +9.83%
11:24AM	Direct-to-consumer IPOs go from boom to bust (Financial Times)
Aug-12-25 09:58AM	2 Stocks Under $50 Worth Your Attention and 1 Facing Challenges (StockStory) +5.12%
03:22AM	WRBY Q2 Deep Dive: Retail Expansion, AI Partnerships, and Margin Leverage Define the Quarter (StockStory)
Aug-11-25 04:45AM	Tariffs Test Warby Parkers Affordable Glasses Strategy (The Wall Street Journal)
Aug-10-25 05:30AM	How Warby Parker Has Kept the Price of Glasses at $95 for 15 Years (The Wall Street Journal)
Aug-07-25 02:32PM	Warby Parker's (NYSE:WRBY) Q2 Sales Top Estimates (StockStory)
09:30AM	Compared to Estimates, Warby Parker (WRBY) Q2 Earnings: A Look at Key Metrics (Zacks)
08:05AM	Warby Parker Inc. (WRBY) Q2 Earnings Match Estimates (Zacks)
07:27AM	Warby Parker to end home try-on program as it focuses on stores, digital experience (Retail Dive)
06:45AM	Warby Parker Announces Second Quarter 2025 Results (Business Wire)
Aug-06-25 07:10AM	National Vision (EYE) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-05-25 11:02PM	What To Expect From Warby Parker's (WRBY) Q2 Earnings (StockStory)
Aug-01-25 01:56PM	Warby Parker, Petco, Tilly's, Abercrombie and Fitch, and RH Shares Plummet, What You Need To Know (StockStory)
07:15AM	Newell Brands (NWL) Q2 Earnings Match Estimates (Zacks)
Jul-31-25 05:25PM	Clorox (CLX) Q4 Earnings and Revenues Top Estimates (Zacks)
10:00AM	Warby Parker Inc. (WRBY) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-23-25 10:00AM	Nordstrom Rack to Open New Location in Mansfield, MA (PR Newswire)
Jul-17-25 06:05PM	Why Warby Parker (WRBY) Stock Is Trading Up Today (StockStory)
04:05PM	Warby Parker to Announce Second Quarter 2025 Financial Results August 7, 2025 (Business Wire)
Jul-09-25 10:31AM	Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. (Barrons.com)
08:25AM	Meta Wants to Reboot the Metaverse. Why AI Glasses Could Hold the Key. (Barrons.com)
Jul-08-25 03:13PM	Meta Invests $3.5 Billion in Worlds Largest Eye-Wear Maker in AI Glasses Push (Bloomberg)
Jul-07-25 11:32PM	Winners And Losers Of Q1: Warby Parker (NYSE:WRBY) Vs The Rest Of The Beauty and Cosmetics Retailer Stocks (StockStory)
02:33PM	Q&A: Warby Parker retail and experience chief talks store evolution, expansion (Chain Store Age)
Jul-04-25 05:30AM	American Companies Hit the Brakes on Hiring (The Wall Street Journal)
05:30AM	American Companies Had Lowest Job Growth in Eight Months (The Wall Street Journal)
Jun-30-25 08:29AM	What Makes Warby Parker (WRBY) an Attractive Investment? (Insider Monkey)
Jun-27-25 08:06AM	The 5 Most Interesting Analyst Questions From Warby Parker's Q1 Earnings Call (StockStory)
Jun-20-25 01:52PM	Meta and Oakley Are Launching AI-Powered Glasses This Summer (Investopedia)
Jun-19-25 12:05AM	Warby Parker (WRBY): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jun-18-25 09:30AM	Grifin Raises $11M Series A to Make Investing as Easy--And Automatic--as Everyday Spending (PR Newswire)
Jun-16-25 03:33PM	Warby Parkers Latest Vision (WWD)
Jun-13-25 10:02AM	RH Q1 Earnings Top Estimates, Revenues Miss, Margins Up Y/Y (Zacks)
Jun-09-25 10:32AM	Was Jim Cramer Right to Be Cautiously Bullish on Warby Parker (WRBY) Last Year? (Insider Monkey)
07:18AM	WRBY Q1 Earnings Call: Management Details Tariff Mitigation, Store Expansion, and Pricing Actions (StockStory)
Jun-02-25 07:00AM	Warby Parker Announces Participation in the Baird Global Consumer, Technology & Services Conference (Business Wire)
May-29-25 09:12AM	Warby Parker partners with Google, adds AI shopping assistant (Retail Dive)
May-28-25 11:57AM	Warby Parker personalizes frame recommendations with AI (Chain Store Age)
May-27-25 09:31PM	It's Unofficially Summer. Time to Get Outside, and Talk With Decking Expert Trex CEO Bryan Fairbanks (Motley Fool)
03:34PM	Loop Capital Maintains Buy Rating on Warby Parker (WRBY) Stock (Insider Monkey)

Warby Parker, Inc. is an online retailer of eyewear for men and women, which engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on May 7, 2010 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Blumenthal Neil Harris	Co-Chief Executive Officer	Jan 13 '26	Sale	29.99	660	19,793	37,119	Jan 15 06:36 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 13 '26	Sale	29.46	80,094	2,359,569	37,247	Jan 15 06:35 PM
DAVID GILBOA	Director	Jan 13 '26	Proposed Sale	26.58	80,094	2,128,899		Jan 13 04:22 PM
NEIL BLUMENTHAL	Director	Jan 13 '26	Proposed Sale	26.58	660	17,543		Jan 13 04:21 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 07 '26	Sale	27.09	75,000	2,031,750	37,247	Jan 09 08:48 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 09 '26	Sale	29.09	19,906	579,066	37,247	Jan 09 08:48 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jan 07 '26	Sale	27.08	50,000	1,354,000	37,119	Jan 09 08:47 PM
DAVID GILBOA	Director	Jan 09 '26	Proposed Sale	28.28	19,906	562,942		Jan 09 04:31 PM
NEIL BLUMENTHAL	Director	Jan 07 '26	Proposed Sale	25.94	50,000	1,297,000		Jan 07 04:25 PM
DAVID GILBOA	Director	Jan 07 '26	Proposed Sale	25.94	75,000	1,945,500		Jan 07 04:24 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jan 06 '26	Sale	25.09	150,000	3,763,500	37,119	Jan 06 08:55 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 06 '26	Sale	24.29	50,000	1,214,500	37,247	Jan 06 08:53 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 02 '26	Sale	22.46	25,000	561,500	37,247	Jan 06 08:53 PM
NEIL BLUMENTHAL	Director	Jan 06 '26	Proposed Sale	23.25	150,000	3,487,500		Jan 06 04:31 PM
DAVID GILBOA	Director	Jan 06 '26	Proposed Sale	23.25	50,000	1,162,500		Jan 06 04:28 PM
DAVID GILBOA	Director	Jan 02 '26	Proposed Sale	21.79	25,000	544,750		Jan 02 04:33 PM
Cutler Joel E	Director	Dec 16 '25	Sale	26.01	19,932	518,477	20,000	Dec 18 04:35 PM
Joel Cutler	Director	Dec 16 '25	Proposed Sale	26.65	32,249	859,436		Dec 16 06:13 PM
Moon Youngme E	Director	Dec 11 '25	Sale	29.07	38,832	1,128,846	27,057	Dec 15 05:30 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 11 '25	Sale	30.29	100,000	3,029,000	37,119	Dec 15 05:29 PM
Raider Jeffrey Jacob	Director	Dec 12 '25	Sale	27.42	25,000	685,500	483,485	Dec 15 05:28 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 11 '25	Sale	30.20	200,000	6,040,000	37,247	Dec 15 05:27 PM
Warby Parker Impact Foundation	10% Owner	Dec 15 '25	Proposed Sale	27.40	178,572	4,892,873		Dec 15 03:16 PM
JEFFREY RAIDER	Officer	Dec 12 '25	Proposed Sale	27.42	25,000	685,618		Dec 12 04:28 PM
David Gilboa	Director	Dec 11 '25	Proposed Sale	29.57	200,000	5,914,000		Dec 11 04:25 PM
NEIL BLUMENTHAL	Director	Dec 11 '25	Proposed Sale	29.57	100,000	2,957,000		Dec 11 04:24 PM
YOUNGME MOON	Director	Dec 11 '25	Proposed Sale	29.07	38,832	1,128,846		Dec 11 04:06 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 02 '25	Option Exercise	0.00	9,816	0	42,677	Dec 04 05:03 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 02 '25	Option Exercise	0.00	9,816	0	42,549	Dec 04 05:02 PM
Gilboa David Abraham	Co-Chief Executive Officer	Oct 01 '25	Sale	27.30	125,000	3,412,500	32,861	Oct 03 05:50 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 18 '25	Sale	27.58	58,360	1,609,569	32,861	Sep 19 05:42 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 17 '25	Sale	27.52	600	16,512	32,861	Sep 19 05:42 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 18 '25	Sale	27.52	8,416	231,608	32,733	Sep 19 05:40 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 17 '25	Sale	27.52	500	13,760	32,733	Sep 19 05:40 PM
David Gilboa	Director	Sep 18 '25	Proposed Sale	26.75	175,000	4,681,250		Sep 18 04:26 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 11 '25	Sale	27.53	41,040	1,129,831	32,861	Sep 15 05:17 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 11 '25	Sale	27.53	41,084	1,131,043	32,733	Sep 15 05:16 PM
NEIL BLUMENTHAL	Director	Sep 11 '25	Proposed Sale	27.01	50,000	1,350,500		Sep 11 04:31 PM
David Gilboa	Director	Sep 11 '25	Proposed Sale	27.01	50,000	1,350,500		Sep 11 04:31 PM
Cutler Joel E	Director	Sep 08 '25	Sale	26.75	35,000	936,352	19,932	Sep 10 08:53 PM
Joel Cutler	Director	Sep 08 '25	Proposed Sale	26.75	35,000	936,250		Sep 08 05:55 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 03 '25	Option Exercise	0.00	9,815	0	38,290	Sep 05 05:15 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 03 '25	Option Exercise	0.00	9,815	0	38,162	Sep 05 05:13 PM
Miller Steven Clive	Chief Financial Officer	Sep 03 '25	Option Exercise	0.00	28,475	0	248,875	Sep 05 05:12 PM
Briggs Teresa	Director	Aug 11 '25	Sale	23.56	6,000	141,360	44,879	Aug 13 08:22 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Aug 13 '25	Sale	25.11	50,000	1,255,500	28,347	Aug 13 08:19 PM
NEIL BLUMENTHAL	Director	Aug 13 '25	Proposed Sale	24.41	50,000	1,220,500		Aug 13 04:22 PM
Teresa Briggs	Director	Aug 11 '25	Proposed Sale	23.56	6,000	141,338		Aug 11 04:05 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jul 21 '25	Sale	24.21	49,600	1,200,816	28,347	Jul 22 06:00 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jul 18 '25	Sale	24.01	400	9,604	28,347	Jul 22 06:00 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jul 21 '25	Sale	24.27	74,500	1,808,115	28,475	Jul 22 05:58 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jul 18 '25	Sale	24.01	500	12,005	28,475	Jul 22 05:58 PM
David Gilboa	Director	Jul 18 '25	Proposed Sale	23.45	75,000	1,758,750		Jul 18 04:47 PM
NEIL BLUMENTHAL	Director	Jul 18 '25	Proposed Sale	23.45	50,000	1,172,500		Jul 18 04:47 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jul 01 '25	Sale	22.04	50,000	1,102,000	28,475	Jul 03 05:00 PM
David Gilboa	Director	Jul 01 '25	Proposed Sale	21.93	50,000	1,096,500		Jul 01 04:32 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jun 03 '25	Option Exercise	0.00	9,816	0	33,905	Jun 05 08:23 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jun 03 '25	Option Exercise	0.00	9,816	0	33,777	Jun 05 08:22 PM
Miller Steven Clive	Chief Financial Officer	Jun 03 '25	Option Exercise	0.00	30,175	0	237,092	Jun 05 08:21 PM
Moon Youngme E	Director	May 22 '25	Sale	19.90	33,073	658,153	53,869	May 27 05:13 PM
Moon Youngme E	Director	May 22 '25	Proposed Sale	19.90	33,073	658,153		May 22 04:29 PM
Miller Steven Clive	Chief Financial Officer	Mar 04 '25	Option Exercise	0.00	27,731	0	216,411	Mar 06 06:02 AM
Miller Steven Clive	Chief Financial Officer	Mar 04 '25	Sale	23.52	11,684	274,808	204,727	Mar 06 06:02 AM
Gilboa David Abraham	Co-Chief Executive Officer	Mar 04 '25	Option Exercise	0.00	3,271	0	52,057	Mar 05 09:57 PM
Gilboa David Abraham	Co-Chief Executive Officer	Mar 04 '25	Sale	23.51	202,968	4,772,513	24,089	Mar 05 09:57 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 04 '25	Option Exercise	0.00	3,271	0	51,928	Mar 05 09:56 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 03 '25	Sale	24.40	150,000	3,659,758	22,569	Mar 05 09:56 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 04 '25	Sale	23.52	27,967	657,784	23,961	Mar 05 09:56 PM
Steven Clive Miller	Officer	Mar 04 '25	Proposed Sale	20.05	13,700	274,721		Mar 04 09:24 PM
David Abraham Gilboa	Director	Mar 04 '25	Proposed Sale	21.93	30,000	657,783		Mar 04 09:24 PM
Neil Harris Blumenthal	Director	Mar 04 '25	Proposed Sale	21.93	30,000	657,783		Mar 04 09:22 PM
NEIL BLUMENTHAL	Director	Mar 03 '25	Proposed Sale	24.73	50,000	1,236,500		Mar 03 05:00 PM

Open in Screener

SGHT

Sight Sciences Inc

Feb 06 • 04:00PM ET

5.87

+0.18 3.16 %

Healthcare • Medical Devices • USA • NASD

SGHT Sight Sciences Inc daily Stock Chart

Peers: ALGN CNMD INSP IRTC MMSI CUTR ARAY SMLR STXS RCEL

| Held by: VTI IWM VXF IWO VTWO DWAS SCHA IWC SMLF VTWG

Index	RUT	P/E	-	EPS (ttm)	-0.90	Insider Own	46.50%	Shs Outstand	52.47M	Perf Week	-6.53%
Market Cap	310.36M	Forward P/E	-	EPS next Y	-0.60	Insider Trans	-0.94%	Shs Float	28.95M	Perf Month	-21.10%
Enterprise Value	258.68M	PEG	-	EPS next Q	-0.15	Inst Own	30.55%	Short Float	4.01%	Perf Quarter	16.70%
Income	-46.11M	P/S	4.08	EPS this Y	27.70%	Inst Trans	0.20%	Short Ratio	4.06	Perf Half Y	65.35%
Sales	76.05M	P/B	4.79	EPS next Y	19.51%	ROA	-35.49%	Short Interest	1.16M	Perf YTD	-25.98%
Book/sh	1.23	P/C	3.36	EPS next 5Y	24.66%	ROE	-57.91%	52W High	9.24 -36.45%	Perf Year	104.53%
Cash/sh	1.75	P/FCF	-	EPS past 3/5Y	8.14% -13.18%	ROIC	-44.16%	52W Low	2.03 189.16%	Perf 3Y	-48.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	17.72% 27.89%	Gross Margin	86.05%	Volatility	7.42% 6.60%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.40	EPS Y/Y TTM	11.70%	Oper. Margin	-59.64%	ATR (14)	0.43	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.93	Sales Y/Y TTM	-4.39%	Profit Margin	-60.63%	RSI (14)	35.50	Recom	1.75
Dividend Gr. 3/5Y	- -	Current Ratio	9.60	EPS Q/Q	29.03%	SMA20	-7.96%	Beta	2.41	Target Price	9.35
Payout	-	Debt/Eq	0.63	Sales Q/Q	-1.25%	SMA50	-21.53%	Rel Volume	0.46	Prev Close	5.69
Employees	216	LT Debt/Eq	0.62	Earnings	Nov 06 AMC	SMA200	19.44%	Avg Volume	286.02K	Price	5.87
IPO	Jul 15, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	36.83% 12.18%	Trades		Volume	130,716	Change	3.16%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-26	Upgrade	Piper Sandler	Neutral → Overweight	$9
Aug-08-25	Upgrade	Lake Street	Hold → Buy	$5
Dec-06-24	Initiated	UBS	Buy	$5.50
Nov-04-24	Downgrade	Lake Street	Buy → Hold	$10 → $5
Aug-21-24	Initiated	Lake Street	Buy	$10
Sep-12-23	Downgrade	William Blair	Outperform → Mkt Perform
Sep-12-23	Downgrade	Piper Sandler	Overweight → Neutral	$15 → $5.50
Sep-12-23	Downgrade	BofA Securities	Neutral → Underperform	$10 → $4.50
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$12 → $8.40
Jul-10-23	Downgrade	Citigroup	Buy → Neutral	$15 → $9
Jan-06-23	Upgrade	Stifel	Hold → Buy	$10 → $15
Oct-04-22	Initiated	Needham	Hold
Jul-26-22	Initiated	Stifel	Hold	$10
Feb-03-22	Initiated	William Blair	Outperform
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$36 → $27

Show Previous Ratings

Jan-21-26 05:41AM	908 Devices (MASS) Moves 19.2% Higher: Will This Strength Last? (Zacks)
Jan-13-26 07:05AM	Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights (GlobeNewswire) -7.83%
Jan-02-26 08:33AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks) -5.67%
Dec-23-25 07:55PM	Sight Sciences price target raised to $12 from $7 at UBS (TipRanks) +7.23%
Dec-18-25 12:00PM	What Makes Sight Sciences, Inc. (SGHT) a Strong Momentum Stock: Buy Now? (Zacks)
09:11AM	Loading…
Dec-05-25 09:11AM	COO Gains as Q4 Earnings & Sales Beat Estimates, MyDay Adoption Rises (Zacks)
09:04AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
Nov-11-25 12:00PM	Sight Sciences (SGHT) Upgraded to Buy: Here's What You Should Know (Zacks) +7.98%
07:00AM	New Peer-Reviewed Publications Highlight Effectiveness of OMNI Surgical System with TruSync Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans (GlobeNewswire)
Nov-06-25 07:30PM	Sight Sciences (SGHT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +16.40%
06:55PM	Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance (GlobeNewswire)
04:04PM	Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer (GlobeNewswire)
Nov-05-25 05:50PM	Steris (STE) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:54AM	What To Expect From Sight Sciences Inc (SGHT) Q3 2025 Earnings (GuruFocus.com)
04:05PM	Loading…
Nov-04-25 04:05PM	Sight Sciences to Present at Two Upcoming Investor Conferences (GlobeNewswire)
Oct-23-25 04:05PM	Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025 (GlobeNewswire)
Oct-17-25 07:00AM	Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare Interventional Dry Eye Procedure (GlobeNewswire) +35.94%
Sep-19-25 07:34AM	SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits (Zacks)
Sep-17-25 07:00AM	Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use (GlobeNewswire)
Sep-09-25 11:39AM	UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures (Benzinga)
07:05AM	Sight Sciences Announces the OMNI Surgical System to be Included in UnitedHealthcare's Expanded Coverage of Glaucoma Surgical Treatments (GlobeNewswire)
Sep-02-25 04:05PM	Sight Sciences Announces Recognition of the TearCare System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO (GlobeNewswire)
10:10AM	Glaukos Builds Dual Growth Engines Amid Market Headwinds (Zacks)
Aug-26-25 04:05PM	Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-07-25 07:00PM	Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics (Zacks) +19.44%
06:50PM	Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance (GlobeNewswire)
Aug-06-25 06:35PM	Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates (Zacks) +5.44%
Jul-30-25 07:00AM	Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease (GlobeNewswire)
07:00AM	Loading…
Jul-29-25 07:00AM	Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare Procedure for the Treatment of Dry Eye Disease (GlobeNewswire)
Jul-24-25 04:05PM	Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire) -5.82%
Jul-09-25 08:18AM	Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks (Zacks)
May-14-25 04:05PM	Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th (GlobeNewswire)
May-09-25 03:41AM	Sight Sciences Inc (SGHT) Q1 2025 Earnings Call Highlights: Navigating Market Challenges and ... (GuruFocus.com)
May-08-25 06:30PM	Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +5.94%
05:45PM	Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance (GlobeNewswire)
May-07-25 11:25AM	Sight Sciences Inc (SGHT) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
May-05-25 05:45PM	Artivion (AORT) Lags Q1 Earnings Estimates (Zacks)
Apr-24-25 04:05PM	Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Apr-23-25 04:05PM	Sight Sciences Announces the Release of its Sustainability Report (GlobeNewswire) +7.36%
Apr-22-25 04:05PM	Sight Sciences Appoints Gary Burbach to its Board of Directors (GlobeNewswire) +8.33%
Apr-21-25 04:05PM	Sight Sciences to Debut OMNI Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio (GlobeNewswire)
Mar-25-25 04:05PM	Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th (GlobeNewswire) -12.38%
Mar-06-25 12:09PM	Q4 2024 Sight Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
02:11AM	Sight Sciences Inc (SGHT) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Challenges (GuruFocus.com)
Mar-05-25 06:00PM	Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics (Zacks)
05:20PM	Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance (GlobeNewswire)
Mar-04-25 07:25AM	Earnings To Watch: Sight Sciences Inc (SGHT) Reports Q4 2024 Result (GuruFocus.com)
Feb-26-25 10:00AM	Will Sight Sciences, Inc. (SGHT) Report Negative Earnings Next Week? What You Should Know (Zacks) +12.85%
Feb-24-25 04:05PM	Sight Sciences to Present Comprehensive Clinical Data on the OMNI Surgical System at the 2025 American Glaucoma Society Annual Meeting (GlobeNewswire)
Feb-19-25 04:05PM	Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025 (GlobeNewswire)
Feb-13-25 04:05PM	Sight Sciences to Present at Citi's 2025 Unplugged MedTech and Life Sciences Access Day (GlobeNewswire) +7.03%
Jan-14-25 08:00AM	Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2024 Financial Highlights (GlobeNewswire)
Jan-07-25 04:05PM	Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma (GlobeNewswire)
Dec-19-24 04:05PM	Sight Sciences Announces the Results of a Budget Impact Analysis for its TearCare System for the Treatment of Meibomian Gland Disease ( MGD ) Showing Cost Savings Over Existing Reimbursed Treatment Options (GlobeNewswire) +6.25%
Dec-07-24 05:31AM	Sight Sciences initiated with a Buy at UBS (TipRanks)
Nov-19-24 04:05PM	Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
Nov-12-24 06:50AM	Sight Sciences price target lowered to $5 from $7 at Morgan Stanley (TipRanks) -7.84%
Nov-08-24 06:02AM	Sight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) -9.62%
Nov-07-24 07:05PM	Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -8.24%
04:05PM	Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance (GlobeNewswire)
04:04PM	Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations (GlobeNewswire)
Nov-06-24 07:43AM	Sight Sciences Inc (SGHT) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com) +8.28%
Oct-17-24 04:05PM	Sight Sciences to Report Third Quarter Financial Results on November 7, 2024 (GlobeNewswire)
Oct-14-24 04:05PM	Single TearCare Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial (GlobeNewswire) +7.67% -5.99%
Aug-21-24 09:36AM	AmEx downgraded, Texas Instruments upgraded: Wall Street's top analyst calls (The Fly)
Aug-20-24 04:05PM	Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-02-24 11:30AM	Q2 2024 Sight Sciences Inc Earnings Call (Thomson Reuters StreetEvents) -14.96%
Aug-01-24 06:45PM	Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance (GlobeNewswire)
Jul-18-24 04:05PM	Sight Sciences to Report Second Quarter Financial Results on August 1, 2024 (GlobeNewswire) -6.13%
Jun-10-24 04:05PM	Sight Sciences Announces the Release of its First Sustainability Report (GlobeNewswire)
May-28-24 04:05PM	Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis (GlobeNewswire) +7.54% +5.51%
08:30AM	Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI Across Mild, Moderate, and Advanced Glaucoma (GlobeNewswire)
May-07-24 04:05PM	Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference (GlobeNewswire)
May-06-24 10:02AM	Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-03-24 01:37PM	Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed (MT Newswires) +6.24%
01:04PM	Q1 2024 Sight Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-02-24 09:55PM	SGHT Stock Earnings: Sight Sciences Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:20PM	Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance (GlobeNewswire)
Apr-30-24 11:02AM	Sight Sciences awarded $34m in Alcon patent infringement case (Medical Device Network)
Apr-29-24 03:55PM	Sector Update: Health Care Stocks Edge Higher Late Afternoon (MT Newswires) +10.23%
01:59PM	Sector Update: Health Care Stocks Rise in Monday Afternoon Trading (MT Newswires)
11:21AM	Update: Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump (MT Newswires)
10:51AM	Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump (MT Newswires)
08:05AM	Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery (GlobeNewswire)
Apr-18-24 04:05PM	Sight Sciences to Report First Quarter Financial Results on May 2, 2024 (GlobeNewswire)
Apr-10-24 04:05PM	Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma (GlobeNewswire)
Apr-02-24 04:05PM	Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting (GlobeNewswire)
Mar-26-24 04:05PM	Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference (GlobeNewswire)
Mar-08-24 02:53PM	Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2023 Earnings Call Transcript (Insider Monkey) +6.09%
09:16AM	Q4 2023 Sight Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-24 10:35PM	Sight Sciences Inc (SGHT) Navigates Challenges to Maintain Revenue Growth and Reduce Expenses (GuruFocus.com)
09:53PM	SGHT Stock Earnings: Sight Sciences Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:50PM	Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates (Zacks)

Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Badawi David	Chief Technology Officer	Jan 16 '26	Sale	6.62	4,836	32,014	1,912,273	Jan 21 04:56 PM
Rodberg James	Chief Financial Officer	Jan 16 '26	Sale	6.62	2,616	17,318	151,230	Jan 21 04:55 PM
Badawi Paul	President and CEO	Jan 16 '26	Sale	6.62	22,362	148,036	6,025,840	Jan 21 04:54 PM
HAYDEN JEREMY B.	Chief Legal Officer	Jan 16 '26	Sale	6.62	6,308	41,759	267,611	Jan 21 04:53 PM
Rodberg James	Officer	Jan 16 '26	Proposed Sale	6.62	2,616	17,311		Jan 16 04:00 PM
Badawi David	Officer	Jan 16 '26	Proposed Sale	6.62	4,836	32,001		Jan 16 03:59 PM
Badawi Paul	Officer	Jan 16 '26	Proposed Sale	6.62	22,362	147,976		Jan 16 03:53 PM
HAYDEN JEREMY B.	Officer	Jan 16 '26	Proposed Sale	6.62	6,308	41,742		Jan 16 03:53 PM
Rogers Erica J.	Former Director	Jan 16 '26	Proposed Sale	6.58	9,748	64,142		Jan 16 03:29 PM
Rogers Erica J.	Former Director	Jan 15 '26	Proposed Sale	6.60	20,000	132,034		Jan 15 04:04 PM
Rogers Erica J.	Former Director	Jan 12 '26	Proposed Sale	7.38	10,000	73,781		Jan 12 04:06 PM
Badawi Paul	President and CEO	Jan 02 '26	Sale	7.43	25,356	188,395	5,937,146	Jan 06 07:10 PM
Badawi Paul	President and CEO	Jan 06 '26	Sale	7.48	11,870	88,788	5,925,276	Jan 06 07:10 PM
HAYDEN JEREMY B.	Chief Legal Officer	Jan 05 '26	Sale	7.82	9,385	73,391	247,205	Jan 06 07:09 PM
HAYDEN JEREMY B.	Chief Legal Officer	Jan 06 '26	Sale	7.48	1,785	13,352	245,420	Jan 06 07:09 PM
Badawi David	Chief Technology Officer	Jan 06 '26	Sale	7.48	3,695	27,639	1,917,109	Jan 06 07:08 PM
Badawi David	Chief Technology Officer	Jan 05 '26	Sale	7.82	3,051	23,859	1,920,804	Jan 06 07:08 PM
Badawi David	Chief Technology Officer	Jan 02 '26	Sale	7.43	2,914	21,651	1,923,855	Jan 06 07:08 PM
Rodberg James	Chief Financial Officer	Jan 05 '26	Sale	7.82	4,405	34,447	154,440	Jan 06 07:04 PM
Rodberg James	Chief Financial Officer	Jan 06 '26	Sale	7.48	594	4,443	153,846	Jan 06 07:04 PM
Bauerlein Alison	Chief Operating Officer	Jan 05 '26	Sale	7.82	10,896	85,207	609,630	Jan 06 07:03 PM
Bauerlein Alison	Chief Operating Officer	Jan 06 '26	Sale	7.48	9,647	72,160	599,983	Jan 06 07:03 PM
Taylor Brenton	EVP, Operations & R&D	Jan 06 '26	Sale	7.48	619	4,630	170,212	Jan 06 07:01 PM
Taylor Brenton	Officer	Jan 06 '26	Proposed Sale	7.48	619	4,631		Jan 06 04:45 PM
HAYDEN JEREMY B.	Officer	Jan 06 '26	Proposed Sale	7.48	1,785	13,355		Jan 06 04:35 PM
Bauerlein Alison	Officer	Jan 06 '26	Proposed Sale	7.48	9,647	72,175		Jan 06 04:34 PM
Badawi David	Officer	Jan 06 '26	Proposed Sale	7.48	3,695	27,645		Jan 06 04:24 PM
Rodberg James	Officer	Jan 06 '26	Proposed Sale	7.48	594	4,444		Jan 06 04:24 PM
Badawi Paul	Officer	Jan 06 '26	Proposed Sale	7.48	11,870	88,807		Jan 06 04:11 PM
Rodberg James	Officer	Jan 05 '26	Proposed Sale	7.82	4,405	34,460		Jan 05 04:28 PM
Bauerlein Alison	Officer	Jan 05 '26	Proposed Sale	7.82	10,896	85,239		Jan 05 04:19 PM
HAYDEN JEREMY B.	Officer	Jan 05 '26	Proposed Sale	7.82	9,385	73,419		Jan 05 04:12 PM
Badawi David	Officer	Jan 05 '26	Proposed Sale	7.82	3,051	23,868		Jan 05 04:10 PM
Badawi Paul	Officer	Jan 02 '26	Proposed Sale	7.43	25,356	188,423		Jan 02 04:21 PM
Badawi David	Officer	Jan 02 '26	Proposed Sale	7.43	2,914	21,654		Jan 02 04:13 PM
Rogers Erica J.	Former Director	Dec 30 '25	Proposed Sale	8.22	10,252	84,223		Dec 30 04:12 PM
Badawi David	Chief Technology Officer	Dec 26 '25	Option Exercise	0.23	21,270	4,892	1,926,769	Dec 30 04:11 PM
Rogers Erica J.	Former Director	Dec 29 '25	Proposed Sale	8.64	20,000	172,804		Dec 29 02:48 PM
Encrantz Staffan	Director	Dec 16 '25	Buy	8.31	13,958	115,963	1,391,922	Dec 18 06:10 PM
Rodberg James	Chief Financial Officer	Dec 02 '25	Sale	8.25	2,518	20,774	158,845	Dec 03 04:19 PM
Rodberg James	Officer	Dec 02 '25	Proposed Sale	8.25	2,518	20,782		Dec 02 04:39 PM
HAYDEN JEREMY B.	Chief Legal Officer	Nov 25 '25	Option Exercise	1.96	44,850	87,906	301,440	Nov 26 06:52 PM
HAYDEN JEREMY B.	Chief Legal Officer	Nov 25 '25	Sale	8.08	44,850	362,388	256,590	Nov 26 06:52 PM
Link Matthew	Former Officer	Nov 26 '25	Proposed Sale	7.82	12,544	98,085		Nov 26 03:45 PM
HAYDEN JEREMY B.	Officer	Nov 25 '25	Proposed Sale	8.08	44,850	362,596		Nov 25 04:53 PM
Link Matthew	Former Officer	Nov 25 '25	Proposed Sale	7.72	55,000	424,721		Nov 25 04:43 PM
Link Matthew	Former Officer	Nov 24 '25	Proposed Sale	7.25	32,893	238,418		Nov 24 04:45 PM
Link Matthew	Former Officer	Nov 21 '25	Proposed Sale	7.05	30,000	211,628		Nov 21 04:58 PM
Link Matthew	Former Officer	Nov 20 '25	Proposed Sale	6.97	3,372	23,503		Nov 20 04:16 PM
Taylor Brenton	EVP, Operations & R&D	Nov 17 '25	Sale	7.06	14,418	101,791	170,831	Nov 18 05:24 PM
Link Matthew	Former Officer	Nov 17 '25	Proposed Sale	7.08	22,000	155,758		Nov 17 04:19 PM
Taylor Brenton	Officer	Nov 17 '25	Proposed Sale	7.06	14,418	101,767		Nov 17 04:05 PM
HAYDEN JEREMY B.	Chief Legal Officer	Nov 12 '25	Option Exercise	1.96	3,150	6,174	259,740	Nov 14 07:48 PM
HAYDEN JEREMY B.	Chief Legal Officer	Nov 12 '25	Sale	8.01	3,150	25,232	256,590	Nov 14 07:48 PM
Link Matthew	Former Officer	Nov 14 '25	Proposed Sale	7.24	10,424	75,506		Nov 14 04:10 PM
HAYDEN JEREMY B.	Officer	Nov 12 '25	Proposed Sale	8.01	3,150	25,228		Nov 12 04:23 PM
Link Matthew	Former Officer	Nov 12 '25	Proposed Sale	7.84	35,049	274,635		Nov 12 04:08 PM
Link Matthew	Former Officer	Nov 11 '25	Proposed Sale	6.96	50,000	347,995		Nov 12 08:11 AM
Link Matthew	Officer	Oct 22 '25	Proposed Sale	5.02	8,867	44,511		Oct 22 03:13 PM
Link Matthew	Officer	Oct 17 '25	Proposed Sale	4.47	10,529	47,015		Oct 17 03:36 PM
Taylor Brenton	EVP, Operations & R&D	Oct 06 '25	Sale	3.37	591	1,992	185,249	Oct 08 08:12 PM
Taylor Brenton	Officer	Oct 06 '25	Proposed Sale	3.37	591	1,992		Oct 06 04:28 PM
Bauerlein Alison	Chief Financial Officer	Oct 02 '25	Sale	3.30	19,948	65,828	597,520	Oct 03 05:53 PM
Badawi Paul	President and CEO	Oct 01 '25	Sale	3.34	24,441	81,633	5,962,502	Oct 03 05:53 PM
Badawi David	Chief Technology Officer	Oct 03 '25	Sale	3.27	6,033	19,728	1,864,992	Oct 03 05:53 PM
HAYDEN JEREMY B.	Chief Legal Officer	Oct 03 '25	Sale	3.27	9,731	31,820	256,590	Oct 03 05:52 PM
Badawi David	Officer	Oct 03 '25	Proposed Sale	3.27	6,033	19,745		Oct 03 04:47 PM
HAYDEN JEREMY B.	Officer	Oct 03 '25	Proposed Sale	3.27	9,731	31,849		Oct 03 04:26 PM
Link Matthew	Former Officer	Oct 03 '25	Proposed Sale	3.29	15,000	49,276		Oct 03 04:25 PM
Bauerlein Alison	Officer	Oct 02 '25	Proposed Sale	3.30	19,948	65,751		Oct 02 03:52 PM
Badawi Paul	Officer	Oct 01 '25	Proposed Sale	3.34	24,441	81,740		Oct 01 04:17 PM
Link Matthew	Former Officer	Sep 23 '25	Proposed Sale	3.53	20,753	73,351		Sep 23 04:38 PM
Link Matthew	Former Officer	Sep 19 '25	Proposed Sale	3.67	20,000	73,400		Sep 19 10:01 AM
Link Matthew	Former Officer	Sep 16 '25	Proposed Sale	3.46	15,990	55,292		Sep 16 03:30 PM
Link Matthew	Former Officer	Sep 12 '25	Proposed Sale	3.52	10,000	35,227		Sep 12 04:18 PM
Badawi David	Chief Technology Officer	Jul 17 '25	Option Exercise	0.12	40,000	4,800	1,871,025	Jul 18 06:36 PM
HAYDEN JEREMY B.	Chief Legal Officer	Jul 03 '25	Sale	4.17	9,160	38,234	266,321	Jul 07 09:32 PM
Bauerlein Alison	Chief Financial Officer	Jul 02 '25	Sale	4.10	19,260	78,927	617,468	Jul 07 09:27 PM
Badawi Paul	President and CEO	Jul 01 '25	Sale	4.15	23,637	98,141	5,986,943	Jul 07 09:27 PM
Badawi David	Chief Technology Officer	Jul 03 '25	Sale	4.17	5,679	23,704	1,831,025	Jul 07 09:25 PM
Link Matthew	Chief Commercial Officer	Jul 02 '25	Sale	4.10	4,889	20,035	832,293	Jul 07 09:24 PM
Badawi David	Officer	Jul 03 '25	Proposed Sale	4.17	5,679	23,705		Jul 03 03:13 PM
HAYDEN JEREMY B.	Officer	Jul 03 '25	Proposed Sale	4.17	9,160	38,236		Jul 03 03:05 PM
Link Matthew	Officer	Jul 02 '25	Proposed Sale	4.10	4,889	20,037		Jul 02 04:45 PM
Bauerlein Alison	Officer	Jul 02 '25	Proposed Sale	4.10	19,260	78,933		Jul 02 04:37 PM
Badawi Paul	Officer	Jul 01 '25	Proposed Sale	4.15	23,637	98,134		Jul 01 04:27 PM
Encrantz Staffan	Director	Jun 05 '25	Buy	4.24	40,951	173,796	1,319,112	Jun 06 09:10 PM
Encrantz Staffan	Director	Jun 06 '25	Buy	4.22	27,900	117,738	1,377,964	Jun 06 09:10 PM
Encrantz Staffan	Director	Jun 04 '25	Buy	4.17	21,674	90,424	1,278,161	Jun 06 09:10 PM
Encrantz Staffan	Director	May 30 '25	Buy	3.67	42,753	156,904	1,200,458	Jun 03 09:57 PM
Encrantz Staffan	Director	Jun 02 '25	Buy	3.88	30,799	119,439	1,231,257	Jun 03 09:57 PM
Encrantz Staffan	Director	Jun 03 '25	Buy	3.97	25,230	100,087	1,256,487	Jun 03 09:57 PM
Encrantz Staffan	Director	May 29 '25	Buy	3.59	60,128	215,739	1,157,705	May 29 09:31 PM
Encrantz Staffan	Director	May 27 '25	Buy	3.44	41,346	142,065	1,070,862	May 29 09:31 PM
Encrantz Staffan	Director	May 28 '25	Buy	3.52	26,715	93,930	1,097,577	May 29 09:31 PM
Bauerlein Alison	Chief Financial Officer	May 19 '25	Sale	3.48	13,066	45,430	636,728	May 21 08:38 PM
Bauerlein Alison	Officer	May 19 '25	Proposed Sale	3.48	13,066	45,430		May 19 03:52 PM
HAYDEN JEREMY B.	Chief Legal Officer	Apr 02 '25	Sale	2.31	9,395	21,693	275,481	Apr 03 09:57 PM
Badawi Paul	President and CEO	Apr 01 '25	Sale	2.30	24,174	55,673	6,010,580	Apr 03 09:56 PM
Link Matthew	Chief Commercial Officer	Apr 02 '25	Sale	2.31	5,042	11,642	830,551	Apr 03 09:56 PM

WRBY

Warby Parker Inc

SGHT

Sight Sciences Inc

Upgrade your FINVIZ experience